EP Patent

EP2440271A1 — Inhaler

Assigned to Ivax Pharmaceuticals Ireland · Expires 2012-04-18 · 14y expired

What this patent protects

An inhaler (10), such as a breath-actuated metered-dose inhaler, for delivering medicament to a patient. The inhaler (10) comprises a housing for holding the medicament and having an air inlet means (12) and a medicament delivery port which together define an air flow path into w…

USPTO Abstract

An inhaler (10), such as a breath-actuated metered-dose inhaler, for delivering medicament to a patient. The inhaler (10) comprises a housing for holding the medicament and having an air inlet means (12) and a medicament delivery port which together define an air flow path into which the medicament is dispensed. The air inlet means (12) comprises an array of elongate apertures (24) formed in the housing, the long sides of adjacent apertures (24) facing each other. Each aperture (24) is provided with a respective different opening in an outer surface of the housing. The opening of each aperture (24) extends in two different planes such that, if at least a part of the opening is covered in one of the two different planes during inhalation by the patient, a void space is created between the cover and the aperture (24) so as to provide an air flow path through the void space to the at least one aperture (24 ).

Drugs covered by this patent

Patent Metadata

Patent number
EP2440271A1
Jurisdiction
EP
Classification
Expires
2012-04-18
Drug substance claim
No
Drug product claim
No
Assignee
Ivax Pharmaceuticals Ireland
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.